Wilhem Leconet
Wilhem Leconet
Weill Cornell Medicine
Dirección de correo verificada de med.cornell.edu
Título
Citado por
Citado por
Año
Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy
W Leconet, C Larbouret, T Chardès, G Thomas, M Neiveyans, M Busson, ...
Oncogene 33 (47), 5405-5414, 2014
622014
Therapeutic activity of anti-AXL antibody against triple-negative breast cancer patient-derived xenografts and metastasis
W Leconet, M Chentouf, S Du Manoir, C Chevalier, A Sirvent, I Aït-Arsa, ...
Clinical Cancer Research 23 (11), 2806-2816, 2017
402017
Sorafenib overcomes irinotecan resistance in colorectal cancer by inhibiting the ABCG2 drug-efflux pump
T Mazard, A Causse, J Simony, W Leconet, N Vezzio-Vie, A Torro, ...
Molecular cancer therapeutics 12 (10), 2121-2134, 2013
402013
Preexisting autoantibodies predict efficacy of oral insulin to cure autoimmune diabetes in combination with anti-CD3
AA Mamchak, Y Manenkova, W Leconet, Y Zheng, JR Chan, CL Stokes, ...
Diabetes 61 (6), 1490-1499, 2012
382012
Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation
Y Lazrek, O Dubreuil, V Garambois, N Gaborit, C Larbouret, ...
Neoplasia 15 (3), 335-IN40, 2013
342013
HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models
G Thomas, T Chardès, N Gaborit, C Mollevi, W Leconet, B Robert, ...
Oncotarget 5 (16), 7138, 2014
332014
CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib‐resistant chronic myeloid leukaemia
R Gioia, C Trégoat, PY Dumas, V Lagarde, V Prouzet‐Mauléon, V Desplat, ...
The Journal of Pathology 237 (1), 14-24, 2015
222015
Nonviral delivery of small interfering RNA into pancreas-associated immune cells prevents autoimmune diabetes
W Leconet, P Petit, S Peraldi-Roux, D Bresson
Molecular Therapy 20 (12), 2315-2325, 2012
112012
Induction of PSMA and Internalization of an Anti-PSMA mAb in the Vascular Compartment
DP Nguyen, PL Xiong, H Liu, S Pan, W Leconet, V Navarro, M Guo, J Moy, ...
Molecular Cancer Research 14 (11), 1045-1053, 2016
102016
Anti-PSMA/CD3 bispecific antibody delivery and antitumor activity using a polymeric depot formulation
W Leconet, H Liu, M Guo, S Le Lamer-Déchamps, C Molinier, S Kim, ...
Molecular cancer therapeutics 17 (9), 1927-1940, 2018
72018
Anti-Axl antibodies and uses thereof
B Robert, B Fauvel, G Cheve, A Yasri, C Larbouret, W Leconet, T Chardes, ...
US Patent 9,409,988, 2016
32016
Anti-Axl antibodies and uses thereof
B Robert, B Fauvel, G Cheve, A Yasri, C Larbouret, W Leconet, T Chardes, ...
US Patent 9,249,228, 2016
32016
HER3 expression as a predictive biomarker of the efficacy of pertuzumab in pancreatic cancer
G Thomas, N Gaborit, W Leconet, B Robert, T Chardes, A Pelegrin, ...
ANNALS OF ONCOLOGY 23, 40-40, 2012
12012
External Beam Irradiation May Increase the Therapeutic Index of J591 Brachytherapy
MK Ramirez-Fort, S Pan, H Liu, V Navarro, J McCormick, M Guo, ...
International Journal of Radiation Oncology• Biology• Physics 99 (2), E261-E262, 2017
2017
Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis
N Radosevic-Robin, W Leconet, M Chentouf, S Du Manoir, C Chevalier, ...
2017
Melanoma Induces Endothelial Folate Hydrolase-1 (FOLH1) Expression and Facilitated Internalization of Immunotheragnostic Agent, J591
MK Ramirez-Fort, B Meier, JR Vissicchio, J Moy, H Liu, E Contassot, ...
International Journal of Radiation Oncology• Biology• Physics 96 (2), E703-E704, 2016
2016
253 Induction of prostate-specific membrane antigen expression (PSMA) expression and internalization of anti-PSMA monoclonal antibodies in human endothelial cells
TPD Nguyen, P Xiong, S Pan, H Liu, M Guo, W Leconet, V Navarro, S Kim, ...
European Urology Supplements 3 (15), e253, 2016
2016
CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia: CBL controls kinase expression
R Gioia, C Trégoat, PY Dumas, V Lagarde, V Prouzet-Mauléon, V Desplat, ...
2015
Folate hydrolase-1 (FOLH1) as a specific therapeutic target for tumor neovasculature in malignant melanoma
MK Ramirez-Fort, H Liu, BD Robinson, S Kim, W Leconet, V Navarro, ...
JOURNAL OF INVESTIGATIVE DERMATOLOGY 135 (8), S6-S6, 2015
2015
Signalisation et ciblage thérapeutique du récepteur tyrosine kinase AXL dans les cancers
W Leconet
Montpellier 1, 2014
2014
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20